These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3732352)

  • 61. Plasma concentrations of C-19 steroids, estrogens, FSH, LH and prolactin in post-menopausal women with an without breast cancer.
    Bird CE; Cook S; Owen S; Sterns EE; Clark AF
    Oncology; 1981; 38(6):365-8. PubMed ID: 6795556
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association of time since last birth, age at first birth and parity with breast cancer survival among parous women: a register-based study from Norway.
    Alsaker MD; Opdahl S; Romundstad PR; Vatten LJ
    Int J Cancer; 2013 Jan; 132(1):174-81. PubMed ID: 22511284
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A case-control study of risk indicators among women with premenopausal and early postmenopausal breast cancer.
    Lipnick R; Speizer FE; Bain C; Willett W; Rosner B; Stampfer MJ; Belanger C; Hennekens CH
    Cancer; 1984 Feb; 53(4):1020-4. PubMed ID: 6692286
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer.
    Camoriano JK; Loprinzi CL; Ingle JN; Therneau TM; Krook JE; Veeder MH
    J Clin Oncol; 1990 Aug; 8(8):1327-34. PubMed ID: 2199619
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
    Tworoger SS; Sluss P; Hankinson SE
    Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serum hormones in human breast cancer subjects.
    Krishnamoorthy G; Govindarajulu P; Ramalingam V
    Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
    Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Circulating levels of prolactin in human breast cancer.
    Sheth NA; Ranadive KJ; Suraiya JN; Sheth AR
    Br J Cancer; 1975 Aug; 32(2):160-7. PubMed ID: 2274
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Perioperative bromocriptine adjuvant treatment for operable breast cancer.
    Fentiman IS; Brame K; Chaudary MA; Camplejohn RS; Wang DY; Millis RR
    Lancet; 1988 Mar; 1(8586):609-10. PubMed ID: 2894547
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Post-mastectomy radiation beyond chest wall in patients with N1 breast cancer: is there a benefit?
    Yadav BS; Sharma SC; George P; Bansal A
    J Cancer Res Ther; 2014; 10(2):279-83. PubMed ID: 25022378
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
    Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
    Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Age related association of Her-2/neu with prognostic markers in female breast carcinoma.
    Sharif MA; Mamoon N; Mushtaq S; Khadim MT
    J Coll Physicians Surg Pak; 2010 Sep; 20(9):590-4. PubMed ID: 20810050
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Survival of women with node negative breast cancer in the Auckland region.
    Lethaby AE; Mason BH; Harvey VJ; Holdaway IM
    N Z Med J; 1996 Sep; 109(1029):330-3. PubMed ID: 8862351
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint
    Makama M; Drukker CA; Rutgers EJT; Slaets L; Cardoso F; Rookus MA; Tryfonidis K; Van't Veer LJ; Schmidt MK
    Eur J Cancer; 2017 Apr; 75():5-13. PubMed ID: 28214658
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diet, prolactin, and breast cancer.
    Baghurst PA; Carman JA; Syrette JA; Baghurst KI; Crocker JM
    Am J Clin Nutr; 1992 Nov; 56(5):943-9. PubMed ID: 1415014
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Importance of serum prolactin determination in metastatic breast cancer patients.
    Mujagić Z; Mujagić H
    Croat Med J; 2004 Apr; 45(2):176-80. PubMed ID: 15103755
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mastectomy stimulates prolactin release in breast cancer patients.
    Holtkamp W; Osterloh B; Rauschecker H; Nagel GA
    Anticancer Res; 1986; 6(4):725-7. PubMed ID: 3752952
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum Prolactin Levels as a Novel, Practical Marker for Predicting Malignant Diseases of the Breast.
    Singh I; Gupta S; Deshmukh M; Gandhi M; Khopkar-Kale P
    Cureus; 2024 Apr; 16(4):e58375. PubMed ID: 38756317
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differential prolactin response to oral metoclopramide in nulliparous versus parous women throughout the menstrual cycle.
    Espinosa de los Monteros A; Cornejo J; Parra A
    Fertil Steril; 1991 May; 55(5):885-9. PubMed ID: 2022267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.